
City of Hope, founded in 1913, is a National Cancer Institute-designated comprehensive cancer center that blends pioneering research, clinical care, and education to deliver cutting-edge treatments for cancer, diabetes, and other life-threatening conditions. Its integrated model spans a Los Angeles campus, a growing network of Southern California sites, and facilities in Atlanta, Chicago, and Phoenix, allowing patients to access world-class diagnostics, therapeutics, and supportive care under one umbrella. The organization’s research portfolio has produced breakthrough cancer drugs, synthetic insulin, and monoclonal antibodies, underscoring its leadership in translational science. City of Hope’s collaborative culture, commitment to training the next generation of scientists and clinicians, and focus on translational genomics distinguish it as a premier institution for those seeking to advance patient care through science and innovation.
City of Hope Atlanta is seeking a Board Eligible or Board-Certified Medical Oncologist to join our esteemed Atlanta team. We offer a collaborative, patient-focused environment dedicated to transforming healthcare by integrating cutting-edge research and compassionate care.
City of Hope, founded in 1913, is a National Cancer Institute-designated comprehensive cancer center that blends pioneering research, clinical care, and education to deliver cutting-edge treatments for cancer, diabetes, and other life-threatening conditions. Its integrated model spans a Los Angeles campus, a growing network of Southern California sites, and facilities in Atlanta, Chicago, and Phoenix, allowing patients to access world-class diagnostics, therapeutics, and supportive care under one umbrella. The organization’s research portfolio has produced breakthrough cancer drugs, synthetic insulin, and monoclonal antibodies, underscoring its leadership in translational science. City of Hope’s collaborative culture, commitment to training the next generation of scientists and clinicians, and focus on translational genomics distinguish it as a premier institution for those seeking to advance patient care through science and innovation.